01194 Filed Pursuant to Rule 424(b)(3)
File Nos. 33-37920
COMMUNITY PSYCHIATRIC CENTERS
1,353,751 Shares
Common Stock
($1.00 Par Value)
COMBINED STOCK OPTION PLAN FOR KEY EMPLOYEES
79,192 Shares
1989 STOCK INCENTIVE PLAN
1,274,559 Shares
This Prospectus Supplement relates to and amends the Prospectus dated
November 14, 1990, as amended by the Prospectus Supplement dated October 16,
1992 (collectively, the "Prospectus") and reflects changes to the Selling
Shareholders information.
This Prospectus Supplement, when attached to the Prospectus, may be used
by the Selling Shareholders in connection with the sale to the public of all or
part of the shares covered by it on the New York Stock Exchange. Such sales
will be at prices and at terms then available in negotiated transactions or
otherwise. The Company will receive no part of the proceeds of any such sale.
Commission expenses and brokerage fees will be payable individually by the
Selling Shareholders.
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
AND EXCHANGE COMMISSION, NOR HAS THE COMMISSION PASSED UPON THE ACCURACY OR
ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.
The date of this Prospectus Supplement is January 5, 1994
<PAGE>
<TABLE> SELLING SHAREHOLDERS
The following table replaces the table contained in the Prospectus and
identifies all persons who are Selling Shareholders who have received or
exercised options under the Plans as of January 5, 1994. As to each Selling
Shareholder, the table shows, as of January 5, 1994 (i) the total number of
shares beneficially owned; (ii) the number of such shares owned which were
purchased upon exercise of options under the Combined Plan; (iii) the number
of shares to be sold hereunder subject to unexercised options granted under
each of the Plans, and (iv) the number of shares to be sold hereunder.
<CAPTION> Number of
Total Shares Total Shares Previously Shares to be Sold Number of
Beneficially Acquired on Exercise of Options Hereunder Subject to Shares to
Owned as of and Still Held on 1/5/94 Options on 1/5/94 <F2> Be Sold
Name and Office 1/5/94 <F1> Combined Combined Incentive Hereunder
<S> <C> <C> <C> <C> <C>
RICHARD L. CONTE,
Chairman of the Board;
Chief Executive Officer -- -- 62,656 407,344 470,000
STEVEN S. WEIS,
Chief Financial Officer -- -- -- 116,000 116,000
JAMES R. LAUGHLIN,
President - Transitional
Hospitals Corporation -- -- -- 116,000 116,000
KAY E. SEIM,
Executive Vice President 44 44 -- 116,000 116,044
DAVID WAKEFIELD,
Director; Executive Vice
President 1,125 1,125 3,458 83,000 87,583
GEOFFREY DEUTSCH,
Executive Vice President -- -- -- 38,000 38,000
RONALD L. OOLEY,
Executive Vice President -- -- -- 18,000 18,000
TERRANCE R. BRIDGES,
Senior Vice President 188 188 -- 58,000 58,188
KATHY BOLMER,
Senior Vice President -- -- -- 10,000 10,000
ARTHUR GINSBERG,
Senior Vice President -- -- -- 10,500 10,500
SUZANNE S. HOVDEY,
Senior Vice President -- -- -- 20,500 20,500
CRAIG JUENGLING,
Senior Vice President -- -- -- 9,000 9,000
LESTER KEIZER,
Senior Vice President -- -- -- 35,000 35,000
CHARLES SMITH,
Senior Vice President -- -- -- 4,000 4,000
STUART VERE,
Senior Vice President -- -- -- 33,000 33,000
PAUL R. EISEMAN,
Senior Vice President - Transitional
Hospitals Corporation -- -- -- 5,000 5,000
ANN MULLENDORE,
Senior Vice President - Transitional
Hospitals Corporation -- -- -- 3,000 3,000
ERICH WOLTERS,
Senior Vice President - Transitional
Hospitals Corporation -- -- -- 4,000 4,000
DAVID BURROUGHS,
Vice President 200 -- -- 5,500 5,500
ROSE DEIGNAN,
Vice President 3 -- -- 5,250 5,250
NICK DEWAN, M.D.,
Vice President -- -- -- 1,500 1,500
ERIC GRAFALS,
Vice President 66 66 538 8,500 9,104
GEORGE BRUTON,
Vice President - Transitional
Hospitals Corporation -- -- -- 3,000 3,000
SANDRA MOORE,
Vice President - Transitional
Hospitals Corporation -- -- -- 3,000 3,000
JOHN-PAUL SENSIBILE, M.D.,
Vice President - Transitional
Hospitals Corporation -- -- -- 3,400 3,400
WILLIAM KLOPPE,
Vice President - Transitional
Hospitals Corporation -- -- -- 3,000 3,000
GRANT KUNISHIGE,
Vice President -- -- -- 3,000 3,000
CHERYL LINDHEIMER,
Vice President -- -- -- 5,000 5,000
MORGAN L. STAINES,
Vice President 464 464 1,403 5,000 6,867
RICHARD WRIGHT,
Vice President -- -- -- 3,000 3,000
MICHAEL W. YOUNGFELLOW,
Vice President 728 -- 250 3,800 4,050
JOHN VIDAURRI,
Vice President - Business
Development -- -- -- 5,500 5,500
GENE WINTERS,
Vice President - Transitional
Hospitals Corporation -- -- -- 3,000 3,000
DAVID L. DENNIS,
Director -- -- -- 15,000 <F3> 15,000
HARTLY FLEISCHMANN,
Director 5,900 -- -- 30,765 <F3> 30,765
JACK H. LINDHEIMER, M.D.,
Director; Corporate Medical
Director 9,800 8,250 -- 31,000 39,250
STEPHEN J. POWERS,
Director -- -- -- 15,000 <F3> 15,000
DANA L. SHIRES, M.D.,
Director 8,250 750 -- 20,000 <F3> 25,750
ROBERT L. THOMAS,
Director -- -- -- 10,000 <F3> 10,000
<F1> In all cases, these holdings represent less than 1% of the outstanding
shares of Common Stock of the Company.
<F2> All options to which the shares offered hereby are subject are fully
vested.
<F3> Includes options on 5,000 shares to be granted automatically on January
26, 1994 at their fair market value on such date.
</TABLE>
